Mpox Vaccination With Two-Shot, Low-Dose Intradermal Approach Produced Similar Antibody Titers Levels Compared With Standard Subcutaneous Dosing Regimen, Study Finds

MedPage Today (12/14, Kahn) reports, “Mpox vaccination with a two-shot, low-dose intradermal approach produced similar antibody titers levels compared with the standard subcutaneous dosing regimen, an observational study showed.” The findings appeared in a New England Journal of Medicine correspondence.